Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Nov 13 2025

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE · · 2 pages · English

Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 13, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dexlansoprazole Delayed-Release Capsules, 30 mg and 60 mg.".

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases